Total Pageviews

15 Common Mistakes Beginner Automation Engineers Make (And How to Avoid Them)

Introduction

Automation testing isn’t just about writing code—it’s about strategy, architecture, and experience. Many beginners dive straight into scripting tests but stumble over "small" mistakes that later snowball into major issues: flaky tests, maintenance nightmares, or confusing reports.

This article compiles the most frequent pitfalls new automation engineers face. The goal isn’t to shame but to educate: why these mistakes hurt and how to sidestep them. Whether you’re starting out or are a seasoned pro, you’ll find actionable insights here.

Examples use Python, but the principles apply to any language.


1. Mistake: One Test, One Assertion

The Trap:
Beginners often rigidly follow "one test, one assertion," splitting checks into tiny tests:

python
def test_check_title():  
    login_page.check_title()  

def test_check_email():  
    login_page.check_email()  

The Problem:

  • Bloated test counts.

  • Harder maintenance.

  • Slower execution.

  • Cluttered reports.

The Fix:
Group logically related checks into scenario-based tests:

python
def test_login_form_validation():  
    login_page.check_title()  
    login_page.check_email()  

Key Takeaway:

  • Split tests by scenarios, not individual assertions.


2. Mistake: Ignoring Test IDs

The Trap:
Relying on brittle selectors like:

python
self.email_input = page.locator("//div//input[@class='...']")  

The Problem:
Tests break with UI changes (e.g., class name updates).

The Fix:
Use dedicated test IDs (e.g., data-testid):

python
self.email_input = page.get_by_test_id("login-email")  

Why It Matters:

  • Stable tests.

  • Immune to UI tweaks.


3. Mistake: Allure Steps Inside Tests

The Trap:
Embedding Allure steps directly in tests:

python
def test_create_user():  
    with allure.step("Create user"):  
        users_client.create_user()  

The Problem:
Duplication. Changing a step requires updating every test.

The Fix:
Move steps to API clients/page objects:

python
class UsersClient:  
    @allure.step("Create user")  
    def create_user(self): ...  

Benefits:

  • Cleaner tests.

  • Centralized step management.


4. Mistake: No API Clients

The Trap:
Calling APIs directly from tests:

python
response = requests.get("http://api/users/1")  

The Problem:

  • URLs scattered everywhere.

  • Maintenance hell.

The Fix:
Wrap APIs in client classes:

python
class UsersClient:  
    def get_user(self):  
        return requests.get(f"{BASE_URL}/users/1")  

Advantages:

  • Single source of truth.

  • Business-readable tests.


5. Mistake: Skipping PageObject

The Trap:
Writing selectors and checks inline:

python
def test_login():  
    email = page.locator("#email")  
    assert email.is_visible()  

The Fix:
Use PageObject pattern:

python
class LoginPage:  
    def __init__(self, page):  
        self.email = page.get_by_test_id("login-email")  

    def assert_visible(self):  
        expect(self.email).to_be_visible()  

Why It’s Better:

  • Changes affect one file.

  • Tests mirror user flows.


6. Mistake: No Parametrization

The Trap:
Copy-pasting tests for different inputs:

python
def test_login_1():  
    login("user1@mail.com", "pass1")  

def test_login_2():  
    login("user2@mail.com", "pass2")  

The Fix:
Use pytest parametrization:

python
@pytest.mark.parametrize("email, password", TEST_DATA)  
def test_login(email, password): ...  

Benefits:

  • Cleaner code.

  • Isolated test reports.


7. Mistake: Hardcoding Values

The Trap:
Embedding configs in tests:

python
def test_api():  
    response = get("http://localhost:8000/users")  

The Fix:
Externalize configurations:

python
# settings.py  
BASE_URL = os.getenv("API_URL")  

# test_api.py  
response = get(f"{settings.BASE_URL}/users")  

8. Mistake: Storing Secrets in Code

The Trap:
Hardcoding credentials:

python
login("admin", "SuperSecret123!")  

The Fix:
Use environment variables/secrets managers:

python
login(os.getenv("TEST_USER"), os.getenv("TEST_PWD"))  

9. Mistake: Unnecessary Async

The Trap:
Using async without a real need:

python
@pytest.mark.asyncio  
async def test_api(): ...  

The Fix:
Keep it synchronous unless testing async features (e.g., WebSockets).


10. Mistake: Dependent Tests

The Trap:
Tests relying on previous test states:

python
user_id = None  

def test_create_user():  
    global user_id  
    user_id = create_user().id  

def test_delete_user():  
    delete_user(user_id)  # Fails if test_create_user fails!  

The Fix:
Isolate tests with fixtures:

python
@pytest.fixture  
def test_user():  
    return create_user().id  

def test_delete_user(test_user):  
    delete_user(test_user)  

11–15. Quick Fixes

  • Avoid "magic numbers": Use HTTPStatus.BAD_REQUEST instead of 400.

  • Group tests: Organize into classes (e.g., TestLoginSuite).

  • Prefer expect() over assert: Better UI test stability.

  • Use data models: Pydantic/dataclasses beat raw dicts.

  • Leverage fixtures: Reduce boilerplate (e.g., scope="session").


Final Thoughts

Automation is engineering, not just scripting. Adopt proven patterns (PageObject, clients, fixtures) early. Refactor relentlessly.

Write tests you’d want to maintain in a year.


Labels (for Blogger.com):
AutomationTesting, SoftwareQA, PythonTesting, TestAutomation, PageObjectPattern, APITesting, Pytest, BestPractices, QualityAssurance, ContinuousTesting, Selenium, Playwright, TestDesign, CodingStandards, TechTips






Chikungunya Virus Outbreak in China: Key Facts, Symptoms, and Prevention



A sudden surge in chikungunya virus cases has hit China, with over 7,000 infections reported across 13 cities in Guangdong province. Authorities have implemented pandemic-style measures, including forced quarantines and door-to-door inspections, to curb the outbreak. This mosquito-borne disease, though rarely fatal, can cause debilitating joint pain lasting months or even years.

In this article, we’ll explore:
✔ What is chikungunya virus?
✔ How does it spread?
✔ Current outbreak details in China
✔ Symptoms and long-term effects
✔ Prevention and vaccine availability
✔ Travel advisories for U.S. citizens


What Is the Chikungunya Virus?

Chikungunya is a mosquito-borne viral disease first identified in Tanzania in the 1950s. The name comes from the Kimakonde language, meaning “that which bends up”, referring to the severe joint pain that contorts patients’ posture.

Key Symptoms:

  • High fever

  • Severe joint pain (often long-lasting)

  • Muscle pain, headache, nausea

  • Fatigue and rash

Unlike dengue or Zika, chikungunya is not contagious between humans—it spreads only through mosquito bites. However, an infected person can pass the virus to a mosquito, which then spreads it further.


Chikungunya Outbreak in China: Latest Updates

  • Ground Zero: Foshan city (Guangdong province) reported the first case on July 8, 2025.

  • Rapid Spread: Over 3,000 new cases in the past week alone.

  • Government Response:

    • Forced hospital quarantine under mosquito nets until recovery.

    • Door-to-door inspections to eliminate stagnant water (mosquito breeding sites).

    • Fines and criminal charges for non-compliance.

    • Innovative measures: Releasing mosquito-eating fish, deploying drones to detect breeding grounds, and introducing predatory "elephant mosquitoes".

Hong Kong reported its first case in a 12-year-old boy, raising concerns about further spread.


Is Chikungunya in the U.S.?

While rare, the U.S. has seen:

  • Locally acquired cases (last reported in 2019).

  • Travel-related infections (199 cases in 2024, 46 so far in 2025).

  • CDC warnings for travelers visiting Brazil, India, Mexico, Thailand, and now China.

CDC Recommendations for Travelers:

✅ Get vaccinated (IXCHIQ or VIMKUNYA if eligible).
✅ Use EPA-registered insect repellent.
✅ Wear long sleeves and pants.
✅ Avoid travel to outbreak zones if pregnant.


Prevention and Treatment

How to Protect Yourself:

  • Eliminate standing water (flower pots, gutters, buckets).

  • Use mosquito nets and window screens.

  • Apply DEET or picaridin-based repellents.

Is There a Vaccine?

  • IXCHIQ: FDA-approved for adults (18+).

  • VIMKUNYA: Approved for ages 12+.

  • Currently recommended only for travelers to high-risk areas.

Treatment Options:

  • No cure—symptom management only.

  • Rest, hydration, pain relievers (avoid aspirin due to bleeding risk).


Conclusion: Should You Be Worried?

The chikungunya outbreak in China is concerning due to its rapid spread and long-term joint complications. While not as deadly as dengue, its debilitating pain makes it a serious public health threat.

Key Takeaways:
🔹 Not contagious person-to-person—only via mosquitoes.
🔹 China’s aggressive measures mirror COVID-era policies.
🔹 Vaccines exist but are limited to high-risk travelers.
🔹 U.S. cases remain rare but travel-related infections are rising.

Stay informed, take precautions, and monitor CDC updates if traveling to affected regions.